Medizinische Universität Graz - Research portal
Strauß Rupert |
Presentations at scientific and public conferences
Mustafa, TB; Moser, E; Perales, C; Posch-Pertl, L; Casazza, M; Wedrich, A; Strauß, RW.
Morbus Stargardt: neueste klinische Entwicklungen der vergangenen fünf Jahre. Eine systematische Literaturrecherche.
Spektrum der Augenheilkunde. 2025; 39(2-3):71-71.-65. Tagung der Österreichsichen Ophthalmologischen Gesellschaft; May 29-31, 2025; Schladming, AUSTRIA. (ISBN: 0930-4282 )
[Poster]
Perales, C; Moser, E; Mustafa, TB; Posch-Pertl, L; Casazza, M; Wedrich, A; Strauß, RW.
Retinitis pigmentosa: klinische Studien der letzten fünf Jahre - eine systematische Literaturrecherche.
Spektrum der Augenheilkunde. 2025; 39(2-3):46-46.-65. Tagung der Österreichsichen Ophthalmologischen Gesellschaft; May 29-31; Schladming, AUSTRIA. (ISBN: 0930-4282 )
[Oral Communication]
Strauß, RW; Fujinami, K; Robson, A; Posch-Pertl, L; Casazza, M; Wedrich, A; Michaelides, M.
Longitudinal changes in electroretinography in patients affected by Stargardt disease
Spektrum der Augenheilkunde. 2025; 39(2-3):52-52.-65. Tagung der Österreichischen Ophthalmologischen Gesellschaft; May 29-31, 2025; Schladming, AUSTRIA. (ISBN: 0930-4282 )
[Oral Communication]
Kong, XR; Wang, YZ; Lbukun, FA; Birch, DG; Traboulsi, E; Sunness, JS; Bernstein, PS; Audo, IS; Michaelides, M; Sadda, SR; Scholl, HP; Zrenner, E; Ip, MS; West, SK; Cideciyan, AV; Strauss, R
Spatial and anatomic parameters from SD-OCT and associations with best corrected visual acuity (BCVA) in ABCA4-associated Stargardt Disease (STGD1)
INVEST OPHTH VIS SCI. 2024; 65(7):-ARVO Annual Meeting; MAY 5-9, 2024; Seattle, USA.
[Poster]
Web of Science
Moser, E; Wedrich, A; Ivastinovic, D; Posch-Pertl, L; Strauß, R
Zugelassene retinale Prothesen: Vergleich, aktueller Wissensstand und Entwicklung - Eine systematische Literaturrecherche.
Spektrum der Augenheilkunde. 2024; 38(2-3):93-93.-64. Tagung der Österreichischen Ophthalmologischen Gesellschaft; May 9-11, 2024; Schladming, Austria. (ISBN: 0930-4282 )
[Oral Communication]
Wang, YZ; Lbukun, FA; Traboulsi, E; Birch, DG; Sunness, JS; Strauss, R; Audo, IS; Michaelides, M; Sadda, SR; Scholl, HP; Zrenner, E; Ip, MS; Cideciyan, AV; Bernstein, PS; Kong, XR
SD-OCT Features and Macular Sensitivity in ABCA4-related Stargardt disease (STGD1)
INVEST OPHTH VIS SCI. 2024; 65(7):-ARVO Annual Meeting; MAY 5-9, 2024; Seattle, USA.
[Poster]
Web of Science
Yanzhao, FAI; Wang, YZ; Cideciyan, AV; Birch, DG; Sunness, JS; Audo, IS; Michaelides, M; Traboulsi, E; Sadda, SR; Ip, MS; Scholl, HP; Strauss, R; Kong, XR
Longitudinal structure-function (S-F) relationship between shortwavelength autofluorescence (SWFAF) and macular sensitivity (MS) in ABCA4-associated Stargardt (STGD1) disease
INVEST OPHTH VIS SCI. 2024; 65(7):-ARVO Annual Meeting; MAY 5-9, 2024; Seattle, USA.
[Poster]
Web of Science
Eidherr, M; Posch-Pertl, L; Großpötzl, M; Bolz, M; Wedrich, A; Strauß, R
Genetische Abklärung mit erweitertem Panel bei erblichen Netzhautdystrophien in der klinischen Praxis
ÖOG; Mai 18-20, 2023; Schladming, AUSTRIA;. 2023.
[Oral Communication]
FullText
Großpötzl, M; Riedl, R; Schließleder, G; Sadda, S; Scholl, H; Wedrich, A; R.W. Strauss
Die Progression der PROM1-assoziierten Stargardt-Krankheit Typ 4 (ProgStar-4), bestimmt durch optische Kohärenztomographie über einen Zeitraum von 24 Monaten (ProgStar-4-Bericht Nr. 2)
ÖOG; Mai 18-20, 2023; Schladming, AUSTRIA;. 2023.
[Oral Communication]
FullText
Rupert W. Strauss, Markus Eidherr, Dominika Podkowinski, Matthias Bolz, Andreas Wedrich
Bilateral Acute M acular N euroretinopathy (AMN) associated
with COVID 19 infection assessed both structurally and functionally
Annual Meeting of the Retina Society; OCT 11-15; New York, U.S.A.. 2023.
[Poster]
Schließleder, G; Großpötzl, M; Riedl, R; Sadda, S; Wedrich, A; Michaelides, M; Strauß, R
Tiefe Phänotypisierung PROM1-assoziierter Netzhautdegeneration – Deep phenotyping of PROM1-associated retinal degeneration
ÖOG; MAI 18-22, 2023; Schladming, AUSTRIA. 2023.
[Oral Communication]
FullText
Strauß, RW.
Von Gentherapie bis Antioxidantien: Therapeutische Ansätze bei Netzhautdystrophie
APOkongress (Kongress der österreichsichen Apothekerkammer) Ein scharfer Blick
auf das kranke Auge - Update Ophthalmologie; MAR 5-8, 2023; Schladming, AUSTRIA. 2023.
[Science to Public]
Strauss, RW; Eidherr, M; Podkowinski, D; Findl, O; Bolz, M; Wedrich, A.
Bilateral Acute Macular Neuroretinopathy Associated With COVID-19
Infection Assessed Both Structurally and Functionally
The Retina Society - 56th Annual Scientific Meeting; OCT 11-14, 2023; New York, NY, U.S.A.. 2023.
[Poster]
Strauss, RW; Großpötzl, M; Schließleder, G; Michaelides, M; Sadda, S; Scholl, HP
The progression of PROM1-associated Stargardt disease type 4 (ProgStar-4) as determined by spectral-domain optical coherence tomography over a 24-months period
DOG; Sep 28-Okt 1, 2023; Berlin. 2023.
[Oral Communication]
FullText
Eidherr, M; Bolz, M; Strauss, R.
Nicht beschriebene Mutationen in einem österreichischen Patientenkollektiv miterblichen Netzhauterkrankungen.
Spektrum der Augenheilkunde. 2022; 36(2-3):70-70.-62. Jahrestagung der Österreichischen Ophthalmologischen Gesellschaft; MAY 26-28, 2022; Villach, AUSTRIA. (ISBN: 0930-4282 )
[Oral Communication]
Glatz, M; Riedl, R; Glatz, W; Schneider, M; Wedrich, A; Bolz, M; Strauss, RW
Blindheit und Sehbehinderung in Österreich
Spektrum der Augenheilkunde. 2022; -62. Jahrestagung der ÖOG; MAY 26-28, 2022; Villach.
[Oral Communication]
Großpötzl, M; Riedl, R; Schliessleder, G; Jewel, ZH; Michaelides, M; Sadda, S; Birch, D; Scholl, HPN; Strauss, RW
The Progression of PROM1-associated Stargardt Disease type 4 (ProgStar-4) as determined by spectral-domain optical coherence tomography over a 24-months period (ProgStar-4 Report No. 2)
Euretina Hamburg 2022; Sep 1-4, 2022; Hamburg, Germany. 2022.
[Oral Communication]
FullText
Großpötzl, M; Schließleder, G; Kalitzeos, A; Sadda, S; Michaelides, M; Strauss, RW
DEEP PHENOTYPING OF PROM1-ASSOCIATED RETINAL DEGENERATION
Euretina 2022; SEP 1-4, 2022; Hamburg, Germany. 2022.
[Onlinepräsentation]
FullText
Schatz, O; Bolz, M; Strauß, R.
Real-Life Daten aus einem tertiären Behandlungszentrum zur Behnadlung der nicht-infektiösen Uveitis mit Adalimumab.
Spektrum der Augenheilkunde. 2022; 36(2-3):57-58.-62. Tagung der Österreichsichen Ophthalmologischen Gesellschaft; MAY 26-28, 2022; Villach, AUSTRIA. (ISBN: 0930-4282 )
[Poster]
Schließleder, G; Kalitzeos, A; Kasilian, M; Singh, N; Wang, Z; Zhihong, JH; Großpötzl, M; Guttmann, A; SriniVas, S; Wedrich, A; Michaelides, MS; Strauss, RW
Deep Phenotyping of PROM1-associated Retinal Degeneration.
DOG 2022; SEP 29-OKT 2; Berlin. 2022.
[Poster]
FullText
Strauß, RW.
Therapie genetischer Netzhauterkrankungen
Herbstfortbildung 2022 der Klinik für Augenheilkunde, ViDia Christliche Kliniken Karlsruhe; SEP 28, 2022; Karlsruhe, GERMANY. 2022.
[Keynote lecture]
Strauss RW
Diagnose und Therapie genetischer Netzhauterkrankungen – Usher Syndrom
Seminar des Vereins Forum für Usher-Syndrom, Hörsehbeeinträchtigung und Taubblindheit; SEP 16-18, 2022; Linz, Austria. 2022.
[Science to Public]
Strauss, RW; Glatz, M; Riedl, R; Glatz, W; Schneider, M; Rohleder, M; Wedrich, A.
Blindness and Visual Impariment in Austria
45th Annual Macula Society Meeting; JUN 7-11, 2022; Berlin, GERMANY. 2022.
[Oral Communication]
Strauss, RW, Michaelides, M; Birch, D; Sadda, S; Grosspoetzl, M: Schliessleder, G; Hu, ZJ; Scholl, HPN.
Evaluation of Spectral-Domain Optical Coherence Tomography forAnalysis of Progression of Atrophy Secondary to Stargardt Disease Type IV After a Period of 24 Months
The Retina Society - 55th Annual Scientific Meeting; NOV 2-5, 2022; Pasadena, CA, U.S.A.. 2022.
[Oral Communication]
FullText
Schonbach, E; Strauss, R; Cattaneo, M; Birch, DG; Cideciyan, AV; Sunness, JS; Fujinami, K; Zrenner, E; Sadda, SR; Scholl, HP
Changes of Fixation Stability and Fixation Location over 24 Months in Stargardt Disease: the ProgStar Study
INVEST OPHTH VIS SCI. Abstracts. 2021; 62(8):-ARVO Annual Meeting
; MAY 1-7, 2021; Virtuell.
[Oral Communication]
Web of Science
Strauss, RW.
Therapie genetischer Netzhauterkrankungen
VIDEBIS Informationsabend; OCT 05, 2021; Linz, Austria. 2021.
[Science to Public]
Fujinami-Yokokawa, Y; Naka, I; Pontikos, N; Arno, G; Yang, LZ; Liu, X; Li, SY; Woo, SJ; Liu, X; Li, SY; Woo, SJ; Moya, R; Tsunoda, K; Miyata, H; Ohashi, J; Strauss, RW; Scholl, HP; Michaelides, M; Fujinami, K
Ethnicity of pathogenic variants in the ABCA4 gene: analysis of allele frequency in the general population.
INVEST OPHTH VIS SCI. 2020; 61(7):-Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO); MAY 01-07, 2020; ELECTR NETWORK.
[Oral Communication]
[OPEN ACCESS]
Web of Science
Strauss, RW; Kong, X; Ip, M; Michaelides, M; Sadda, S; Sahel, JA; Bernstein, P; Cideciyan, A; Audo, I; Birch, D; Sunness, J; West, S; Scholl HPN.
Progression of Stargardt Disease as Measured by Spectral-Domain Optical Coherence Tomography (SD-OCT) in the ProgStar Study
44th Annual Macula Society Meeting; FEB 19 - 22, 2020; San Diego, California, USA. 2020.
[Oral Communication]
FullText
Strauss, RW; Kong, X; Ho A; Ip, M; Michaelides, M; Sadda, S; West, S; Scholl, HPN.
Progression of Stargardt Disease as Measured by Spectral-domain Optical Coherence Tomography (SD-OCT) in the ProgStar Study
52nd Annual Scientific Meeting of the Retina Society; SEP 11-15, 2019; London, UNITED KINGDOM. 2019.
[Oral Communication]
FullText
Chan, CS; Ho, A; Jenkins, D; Pitetta, S; Li, M; Tassy, J; Strauss, RW; Scholl, HP; Sadda, SR; Ip, MS
Reproducibility of a Modified Dual Grading Model Applied to Fundus Autofluorescence Measurements in Macular Atrophy Secondary to Stargardt Disease
INVEST OPHTH VIS SCI. . 2018; 59(9):-Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO); APR 29-MAY 03, 2018; Honolulu, HI.
[Poster]
Web of Science
Strauss, R; Kong, X; Ho, A; Michaelides, M; Ip, S; West, SH; Scholl, HPN
Progressionsanalyse von Morbus Stargardt mittels spectral-domain optical coherence tomography (SD-OCT) in der multizentrischen ProgStar-Study - Progression of Stargardt disease as measured by spectral-domain optical coherence tomography (SD-OCT) in the multicenter ProgStar-Study
Spektrum der Augenheilkunde. 2018; 32(2):86-86.-59. Tagung der Österreichischen Ophthalmologischen Gesellschaft
59. Annual Meeting of the Austrian Ophthalmic Society ; May 10-12; Schladming, Austria.
[Oral Communication]
Strauss, RW.
Brief summary of the FAF methods and findings
A workshop on Stargardt disease: measuring progression in the ProgStar-study; Jun 11, 2018; Baltimore, MD, U.S.A.. 2018.
[Oral Communication]
Strauss, RW; Kong, K; Munoz, BE; West, SH; IP, MS; Ho, A; Jha, A; Bernstein, PS; Birch, DG; Cideciyan, AC; Michaelides, M; Sahel, JA; Sunness, JS; Traboulsi, EI; Zrenner, E; Scholl, HP.
Progression of Stargardt disease as measured by spectral-domain optical coherence tomography (SD-OCT) in the ProgStar-study
Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO); Apr 29 - May 2; Honolulu, U.S.A.. 2018.
[Oral Communication]
Strauss, RW; Kong, X; Ho, A; Michaelides, M; Ip, M; West, SH; Scholl, HPN.
Progression of Stargardt disease as measured by spectral-domain optical coherence tomography (SD-OCT) in the ProgStar Study
18th Euretina Congress - Annual Meeting of the European Society of Retinal Specialists; Sep 20-23; Vienna, AUSTRIA. 2018.
[Oral Communication]
Strauss, RW.
Is there a possibility of a drug therapy for Stargardt’s disease?
"Stargardt’s Day 2017" by the NIHR Moorfields Biomedical Research Centre and UCL Institute of Ophthalmology ; MAR 18, 2017; London, UNITED KINGDOM. 2017.
[Science to Public]
Strauss, RW; Kong, X; Ho, A; Jha, A; Michaelides, M; Cideciyan, AV; Sahel, JA; Birch, DG; Hariri, AH; Sadda, SR; West, SH; Scholl, HP.
Progression of Atrophic Lesions Determined by Fundus Autofluorescence: The Natural History of the Progression of Atrophy secondary to Stargardt Disease (ProgStar) Study.
Annual Meeting of the Association for Research in Vision and Ophthalmology.; May 6-11; Baltimore. 2017.
[Oral Communication]
Strauss, RW; Kong, X; Ho, a; Michaelides, M; Sadda, S; West, SH; Scholl, HPN.
Jährliche Atrophieprogression beim Morbus Stargardt anhand von Fundusautofluoreszenz-Bildern: die ProgStar-Studie - Progression of Atrophic lesions determined by Fundus Autofluorescence: The Natural History of the Progression of Atrophy secondary to Stargardt Disease (ProgStar) Study
Spektrum der Augenheilkunde . 2017; 31(2):74-74.-58. Tagung der österreichischen Ophthalmologischen Gesellschaft - Annual Meeting of the Austrian Ophthalmic Society; May 25-27; Villach, Austria.
[Oral Communication]
Strauss, RW; Kong, X; Michaelides, M; Ho, A; Sadda, S; West, SH; Scholl, HPN.
Progression of atrophic lesions determined by funds autofluorescence: The natural history of the progression of atrophy secondary to Stargardt Disease (ProgStar) study.
17th Euretina Congress - The Society of European retinal specialists; Sep 7-10; Barcelona, Spain. 2017.
[Oral Communication]
Strauss, RW.
The ProgStar Study – an update
Retinal Degeneration – Potsdam Meeting der ProRetina Stiftung 2016; APR 8-9, 2016; Potsdam, GERMANY. 2016.
[Science to Public]
Strauss, RW.
Genetisch bedingte Netzhauterkrankungen - Stand der Forschung und Therapieausblicke
XXXVI. Kongress für Blinden- und Sehbehindertenpädagogik; AUG 01-05, 2016; Graz, AUSTRIA. 2016.
[Science to Public]
Strauss, RW; Kong, X; Ho, a; Michaelides, M; West, SH; Sadda, S; Scholl, HPN
Progression of atrophic lesions prospectively determined by fundus autofluorescence: The natural history of the progression of atrophy secondary to Stargardt disease (ProgStar) study
16th Euretina Congress. Annual Meeting of the European Retinal Specialists; Sep 8-11; Copenhagen, Denmark. 2016.
[Oral Communication]
Strauss, RW; Kong, X; Jha, A; Bernstein, PS; Michaelides, M; Sahe,l JA; Traboulsi EI, Zrenner E, West SK, Sadda SR, Scholl HP.
Progression of atrophic lesions prospectively determined by fundus autofluorescence: the natural history of the progression of atrophy secondary to Stargardt disease (ProgStar) study.
Annual Meeting of the Association for research in vision and Ophthalmology (ARVO); May 1-5; Seattle, WA, U.S.A.. 2016.
[Oral Communication]
Bomotti, S; Strauss, RW; Scholl, HP; Wojciechowski, R
ABCA4 variants in Stargardt disease: Preliminary results from the ProgStar study
INVEST OPHTH VIS SCI. 2015; 56(7):-Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO); MAY 03-07, 2015; Denver, CO.
[Poster]
Web of Science
Bomotti, S; Strauss, RW; Scholl, HPN; Wojciechowski, R
ABCA4 variants in Stargardt disease: Preliminary results from the ProgStar study.
Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO); MAY 3-7, 2015; Denver, Colorado, USA. 2015.
[Poster]
Bomotti, SM; Strauss, RW; Scholl, HP; Wojciechowski, R
The distribution of ABCA4 variants in Stargardt disease from the ProgStar studies
GENET EPIDEMIOL. 2015; 39(7):535-535.-Annual Meeting of the International-Genetic-Epidemiology-Society (IGES); OCT 04-06, 2015; Baltimore, MD.
[Oral Communication]
Web of Science
Ervin, AM; Munoz, BE; Strauss, RW; Wolfson, Y; Kong, XR; West, SK; Scholl, HP
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Baseline Demographics and Ocular Characteristics
INVEST OPHTH VIS SCI. 2015; 56(7):-Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO); MAY 03-07, 2015; Denver, CO.
[Poster]
Web of Science
Ervin, AM; Munoz, BM; Strauss, RW; Wolfson, Y; Kong, X; West, SK; Scholl, HPN
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Baseline Demographics and Ocular Characteristics.
Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO); MAY 3-7, 2015; Denver, Colorado, USA. 2015.
[Poster]
Ho, A; Kuehlewein, L; Hariri, A; Wolfson, Y; Strauss, RW; Scholl, HPN, Sadda, SR
Quantitative Characteristics of Spectral-Domain Optical Coherence Tomography (SDOCT) in Corresponding Areas of Decreased Autofluorescence in Patients with Stargardt Disease.
Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO); MAY 3-7, 2015; Denver, Colorado, USA. 2015.
[Poster]
Ibrahim, M; Strauss, RW; Wolfson, Y; Kong, X; Munoz, BM; Ho, A; Sadda, SR; West, SK; Scholl, HPN
Assessment of Macular Function with Microperimetry (MP1) in Patients with Stargardt Disease.
Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO); MAY 3-7, 2015; Denver, Colorado, USA. 2015.
[Oral Communication]
FullText
Ibrahim, M; Strauss, RW; Wolfson, Y; Kong, XR; Munoz, BE; Ho, A; Sadda, SR; West, SK; Scholl, HP
Assessment of Macular Function with Microperimetry (MP1) in Patients with Stargardt Disease
INVEST OPHTH VIS SCI. 2015; 56(7):-Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO); MAY 03-07, 2015; Denver, CO.
[Oral Communication]
Web of Science
Kasilian, M; Ring, M; Strauss, RW; Razeen, M; Dubra, A; Peto, T; Bunce, C; Carroll, J; Dubis, AM; Michaelides, M
Reliability of cone density measurements on adaptive optics images in Stargardt disease.
Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO); MAY 3-7, 2015; Denver, Colorado, USA. 2015.
[Poster]
Kong, X; Strauss, RW; Munoz, BE; Wolfson, Y; Ervin, AM; Sadda, SR; West, SK; Scholl, HPN
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Associations between Fundus Autofluorescence and Microperimetry at Baseline of the Prospective Study.
Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO); MAY 3-7, 2015; Denver, Colorado, USA. 2015.
[Oral Communication]
Kong, XR; Strauss, RW; Munoz, BE; Wolfson, Y; Ervin, AM; Sadda, SR; West, SK; Scholl, HP
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Associations between Fundus Autofluorescence and Microperimetry at Baseline of the Prospective Study
INVEST OPHTH VIS SCI. 2015; 56(7):-Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO); MAY 03-07, 2015; Denver, CO.
[Oral Communication]
Web of Science
Munoz, BE; Kong, X; Strauss, RW; Wolfson, Y; Ervin, AM; West, SK; Scholl, HPN
Visual Acuity Loss in the Retrospective Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar-1) Study.
Annual Meeting of the Association for Research in Vision of Ophthalmology (ARVO); MAY 3-7, 2015; Denver, Colorado, USA. 2015.
[Oral Communication]
Munoz, BE; Kong, XR; Strauss, RW; Wolfson, Y; Ervin, AM; West, SK; Scholl, HP
Visual Acuity Loss in the Retrospective Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar-1) Study
INVEST OPHTH VIS SCI. 2015; 56(7):-Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO); MAY 03-07, 2015; Denver, CO.
[Oral Communication]
Web of Science
Shah, SM; Kong, XR; Ho, A; Sadda, SR; Munoz, BE; Strauss, RW; Ibrahim, M; Wolfson, Y; West, SK; Scholl, HP
Fundus Autofluorescence Characteristics in the Natural History of the Progression of Atrophy secondary to Stargardt Disease (PROGSTAR) Study
INVEST OPHTH VIS SCI. 2015; 56(7):-Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO); MAY 03-07, 2015; Denver, CO.
[Oral Communication]
Web of Science
Strauß, RW; Muñoz, BE; Ho, A; West, SK; Sadda, SR; Kong, X; Scholl, HPN
The Natural History of the progression of Atrophy secondary to Stargardt Disease studies (ProgStar): yearly progression rate of atrophic lesions in the retrospective study.
Spektrum der Augenheilkunde. 2015; 29(2):54-54.-56. Tagung der österreichischen ophthalmologischen Gesellschaft; 14.-16. Mai 2015; Villach, Austria. (ISBN: 0930-4282 )
[Oral Communication]
Strauss RW
Terapias emergentes por las Enfermedades retinianas hereditarias
XI Congreso Internacional de la Sociedad Argentina de Retina y Vitreo (SARYV); OCT 28-30, 2015; Buenos Aires, Argentina. 2015.
[Keynote lecture]
FullText
Strauss, RW; Ho, A; Munoz, BM; Ahmed, M; Sadda, SR; Scholl, HPN
The natural history of the progression of atrophy secondary to Stargardt disease studies (ProgStar): yearly progression rate of atrophic lesions in the retrospective study.
Meeting of the International Society for Genetic Eye Diseases & Retinoblastoma (ISGEDR); AUG 6-8, 2015; Halifax, Nova Scotia, Canada. 2015.
[Oral Communication]
Strauss, RW; Kong, X; Muñoz, BE;, Ho, A; Wolfson , Y; Sadda, SR; West SE; Scholl, HPNS
for the ProgStar Study Group
Yearly Progression Rates of Visual Acuity in the Retrospective
Natural History of Progression of Atrophy Secondary Disease (ProgStar) Study
Annual Meeting of the "American Society of Retina Specialists"; Luy 11-14, 2015; Vienna, Austria. 2015.
[Poster]
Strauss, RW; Kong, X; Munoz, BM; Ho, A; Wolfson, Y; Sadda, SR; West, SK; Scholl, HPN
To Provide Yearly Progression Rates of Visual Acuity in the Retrospective Natural History of Progression of Atrophy Secondary Disease (ProgStar) Study.
Abstractband. 2015; -33rd Annual Meeting of the American Society of Retina Specialists; July 11-15, 2015; Vienna, Austria.
[Poster]
Strauss, RW; Michaelides, M; West, SK; Kong, X; Munoz, B; Sadda, S; Scholl, HPN
Visual Acuity Loss in the Retrospective Natural History of the Progression of Atrophy Secondary to Stargardt
Disease (ProgStar-1) Study.
Congress 2015 Final Programme. 2015; 35-35.-Annual Meeting of the Royal College of Ophthalmologists; May 19-21, 2015; Liverpool, United Kingdom.
[Poster]
FullText
Strauss, RW; Munoz, BE; Ho, A; Wolfson, Y; Sadda, SR; Kong, XR; West, SK; Scholl, HP
The Natural History of the Progression of Atrophy secondary to Stargardt Disease studies (ProgStar): yearly progression rate of atrophic lesions in the retrospective study
INVEST OPHTH VIS SCI. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO). 2015; 56(7):-Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO); MAY 03-07, 2015; Denver, CO.
[Oral Communication]
Web of Science
Strauss, RW; Munoz, BM; Ho, A; Kong, X; Sadda, SR; West, SK; Scholl, HPN
The natural history of the progression of atrophy secondary
to Stargardt disease studies (ProgStar): Yearly progression
rate of atrophic lesions in the retrospective study.
15th EURETINA Congress; SEP 17-20, 2015; Nice, France. 2015.
[Oral Communication]
Strauss, RW; Munoz, BM; Wolfson, Y; Sadda, SR; Kong, X; West, SK; Scholl, HPN
The Natural History of the Progression of Atrophy secondary to Stargardt Disease studies: yearly progression rate of atrophic lesions in the retrospective study.
Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO); MAY 3-7, 2015; Denver, CO, USA. 2015.
[Oral Communication]
Wolfson, Y; Fletcher, E; Strauss, RW; Scholl, HP
Evidence of Macular Pigment in the Central Macula in Albinism
INVEST OPHTH VIS SCI. 2015; 56(7):-Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO); MAY 03-07, 2015; Denver, CO.
[Poster]
Web of Science
Wolfson, Y; Fletcher, E; Strauss, RW; Scholl, HPN
Evidence of Macular Pigment in the Central Macula in Albinism.
Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO); MAY 3-7,2015; Denver, Colorado, USA. 2015.
[Poster]
Strauß, RW; Munoz, B; Sophie, R; Wolfson, Y; Scholl, HPN
Progression of retinal
atrophy in Stargardt’s Macular Dystrophy estimated from
spectral-domain optical coherence tomography measurements
of macular volume Progressionsanalyse der
retinalen Atrophie bei Morbus Stargardt anhand von Messungen
mittels sd-OCT
Spektrum Augenheilkd (2014) 28:35–74
55. Tagung der Österreichischen ophthalmologischen Gesellschaft
Spektrum der Augenheilkunde, Sonderheft zur 55. Tagung der Österreichischen Ophthalmologischen Gesellschaft (ÖOG), 29. - 31. Mai 2014, Schladming
. 2014; 2 (2014):60-60.-55. Tagung der Österreichischen Ophthalmologischen Gesellschaft; May 29-31, 2014; Schladming, Austria.
[Oral Communication]
FullText
Strauss, RW; Munoz, B; Fletcher, E; Wolfson, Y; Bittencourt, MG; Scholl, HPN
Progression of retinal atrophy in Stargardt’s
Macular Dystrophy estimated from spectral-domain
optical coherence tomography measurements of
macular volume
THE ROYAL COLLEGE OF OPHTHALMOLOGISTS ANNUAL CONGRESS 2015
. 2014; -The Royal College of Ophthalmologists Annual Congress 2014; May 20-22, 2014, The ICC Birmingham; Birmingham, United Kingdom.
[Poster]
Strauss, RW; Fletcher, E; Wolfson, Y;
Scholl, HP
Yearly Loss of Retinal Thickness and Macular Volume Estimated from SPECTRALIS OCT Measurements in Patients with Stargardt Macular Dystrophy.
2013 Annual Meeting of the Association for Research in Vision and Ophthalmology. 2013; -2013 ARVO Annual Meeting; May 5-9, 2013; Seattle, Washington, U.S.A..
[Poster]
Strauß, RW; Huml, M; Schilcher, K; Dirisamer, M; Faschinger, CW; Priglinger, SG
Charakterisierung der Oberflächen von IOL-Implantationssystemen mittels Atomkraftmikroskopie.
Spektrum der Augenheilkunde. 2012; 26(2):77-78.-Tagung der Österreichischen Ophthalmologischen Gesellschaft; May 2012, 17-19; Villach, Austria.
[Oral Communication]
Strauß, RW; Diesenberger, D; Schilcher, K; Alge-Priglinger, C; Wedrich, A; Priglinger SG.
Untersuchung elastischer Eigenschaften der Hornhaut mit dem Atomkraftmikroskop (AFM)
Spektrum der Augenheilkunde. 2011; 25(2):110-110.-52. Jahrestagung der österreichischen ophthalmologischen Gesellschaft; JUN 2-4, 2011; Mayrhofen im Zillertal, Austria.
[Oral Communication]
Strauß, RW; Hochleitner, M; Köberl, E; Schilcher, K; Alge-Priglinger, C; Faschinger, C; Wedrich, A; Priglinger, SG.
Messung der Hornhautelastizität mittels Atomkraftmikroskopie (AFM)
Programm
Herausforderungen der Augenheilkunde. 2011; -109. DOG-Kongress; Sep 29 - Oct 2, 2011; Berlin, Germany.
[Poster]
Strauss, RW; Diesenberger, D; Schilcher, K; Alge-Priglinger, C; Faschinger, C; Priglinger SG.
Elasticity measurements of untreated and cross linked corneas assessed by atomic force microscopy
Final Programme & Abstracts 2011. 2011; -Annual Congress of the Royal College of ophthalmologists; 24-26 May, 2011; Birmingham, UK.
[Oral Communication]
Strauß, RW; Diesenberger, D; Dirisamer, M; Dichtl,M ; Wedrich, A; Schilcher, K; Priglinger, SG.
Darstellung der kornealen Ultrastruktur vor und nach Crosslinkbehandlung mit der „Atomic Force Microscopy “ (Vortrag) – Atomic force microscopy of the corneal ultrastructure before and after corneal crosslink
Spektrum der Augenheilkunde
Zeitschrift der Österreichischen Ophthalmologischen Gesellschaft Journal of the Austrian Ophthalmic Society. 2010; 24(2):85-86.-51. Tagung der Österreichischen Ophthalmologischen Gesellschaft; May 13-15, 2010; Zell am See, Austria.
[Oral Communication]
Strauss, RW; Diesenberger, D; Dirisamer, M; Dichtl, M; Wedrich, A; Schilcher K; Priglinger SG.
Atomic Force Microscopy of the corneal ultrastructure before and after corneal crosslinking
XXXII International Congress of Ophthalmology
108th DOG Congress
Final program. 2010; -XXXII International Congress of Ophthalmology
108th DOG Congress; June 5-9, 2010; Berlin, Germany.
[Oral Communication]
Strauss, RW;Diesenberger, D;Dirisamer, M;Dichtl, M;Wedrich, A; Schilcher, S;Priglinger, SG
Darstellung der kornealen Ultrastruktur vor und nach Crosslinkingbehandlung mit der "Atomic Force Mic
roscopy"
Spektrum der Augenheilkunde2010; 24(2):85-86.-51. Tagung der Österreichischen Ophthalmologischen Gesellschaft; MAY 13-15, 2010; Zell am See, AUSTRIA.
[Oral Communication]
Strauß, RW; Gsenger, W; Schilcher, K; Burger, J; Priglinger, SG
Characterization of IOL-surfaces using the "atomic force microscope"
Spektrum der Augenheilkunde
Zeitschrift der Österreichischen Ophthalmologischen Gesellschaft. 2009; 23(2):59-167.-50. Jahrestagung der Österreichischen Ophthalmologischen Gesellschaft; May 21-23, 2009; Bad Ischl, Austria.
[Oral Communication]
Strauß, RW; Dichtl, M; Dirisamer, M; Wildmann, E; Priglinger, C; Burger, J; Priglinger, SG
Brilliantcresylblauassistierte Makulachirurgie (Vortrag) – brilliantcresylblue-assisted vitreoretinal surgery
Spektrum der Augenheilkunde. 2008; 22(2):84-85.-49. Tagung der Österreichischen Ophthalmologischen Gesellschaft; Mai 1-3, 2008; Graz, Austria.
[Oral Communication]
Strauss, RW; Wolf, A; Ulbig, MW; Kampik, A; Neubauer, AS.
Korrelation zwischen Fundus-Autofluoreszenz und Optischer Kohärenztomographie bei Patienten mit trockener AMD
105. DOG-Kongress ; September 20-23, 2007; Berlin, Germany. 2007.
[Oral Communication]
FullText
Strauss, RW; Neubauer, AS; Kampik, A
Topographische, 3D und quantitative Darstellung der Autofluoreszenz bei trockener altersabhängiger Makuladegeneration
Topographic, 3D and quantitative analysis of autofluorescence in dry age-related macular degeneration
104th DOG congress (Deutsche Ophthalmologische Gesellschaft); September 21-24, 2006; Berlin, Germany. 2006.
[Oral Communication]
FullText
Wolf, A; Kook, D; Priglinger, S; Haritoglou, C; Hofer, A; Strauß, R; Gandorfer, A; Ulbig, M; Kampik, A
Subgruppenanalyse nach intravitrealer Anti-VEGF-Therapie bei Patienten mit neovaskulärer AMD
Analysis of subgroups after intravitreal Anti-VEGF therapy for neovascular AMD
104th DOG Annual Meeting; September 21-24, 2006; Berlin, Germany. 2006.
[Oral Communication]
FullText
Strauss, RW; Thiel, MJ; Ulbig, MW; Kampik, A; Neubauer, AS
Artefacts in Optical Coherence tomography (OCT) imaging of the retina
EVER 2005
Programme. 2005; -Annual Meeting of the European Association for Vision and Eye Research (EVER); October 5-8, 2005; Vilamura, Portugal.
[Oral Communication]
Strauss, RW; Thiel, MJ; Ulbig, MW; Kampik, A; Neubauer, AS
Artefacts in optical coherence tomography imaging (OCT) of the retina.
Artefakte in der Optischen Koehaerenz-Tomographie (OCT) der Netzhaut
Final Programme. 2005; -Joint Meeting
15th SOE Congress (Societas Ophthalmologica Europeae)
103rd DOG congress (Deutsche Ophthalmologishce Gesellschaft); September 25-29, 2005; Berlin, Germany.
[Oral Communication]
Strauss, RW; Welge-Luessen, UC; Priglinger, SG; Kampik, A; Neubauer AS
Effect of Image Quality and Sample Size on Manual and Automatic Endothelial Cell Counts
Annual Meeting of the European Eye Bank Association; January 24-26, 2005; Halle, Germany. 2005.
[Oral Communication]
FullText